Matches in Nanopublications for { ?s ?p "[The antioxidant effect of PPARgamma is exclusively mediated by GPx3 and further imply that GPx3 may be a therapeutic target for insulin resistance and diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP120926.RAnQyNvqUjZ6k3oqGXaxBctLnTuClUr9oUkwWTY-waY8Q130_assertion description "[The antioxidant effect of PPARgamma is exclusively mediated by GPx3 and further imply that GPx3 may be a therapeutic target for insulin resistance and diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120926.RAnQyNvqUjZ6k3oqGXaxBctLnTuClUr9oUkwWTY-waY8Q130_provenance.
- NP120800.RAOTf9u3GWd-0UCiA_mvUWG3OFLcHTUlaD2lQb9O08Z0k130_assertion description "[The antioxidant effect of PPARgamma is exclusively mediated by GPx3 and further imply that GPx3 may be a therapeutic target for insulin resistance and diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP120800.RAOTf9u3GWd-0UCiA_mvUWG3OFLcHTUlaD2lQb9O08Z0k130_provenance.
- assertion description "[The antioxidant effect of PPARgamma is exclusively mediated by GPx3 and further imply that GPx3 may be a therapeutic target for insulin resistance and diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The antioxidant effect of PPARgamma is exclusively mediated by GPx3 and further imply that GPx3 may be a therapeutic target for insulin resistance and diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP183991.RADYRT1ZjbW9CyF9uZ7AdWGtSF4s1qXotrPAUigl-bc5E130_assertion description "[The antioxidant effect of PPARgamma is exclusively mediated by GPx3 and further imply that GPx3 may be a therapeutic target for insulin resistance and diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP183991.RADYRT1ZjbW9CyF9uZ7AdWGtSF4s1qXotrPAUigl-bc5E130_provenance.
- NP184115.RAy1fWMjFNnF4pGF8XEtfoKZoryDrWHXXA7MeIRDRYrt8130_assertion description "[The antioxidant effect of PPARgamma is exclusively mediated by GPx3 and further imply that GPx3 may be a therapeutic target for insulin resistance and diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184115.RAy1fWMjFNnF4pGF8XEtfoKZoryDrWHXXA7MeIRDRYrt8130_provenance.
- NP242985.RAP6X7qo53l3MJdcHHWYo7WcYq0nnk5th59nRek1qCqZs130_assertion description "[The antioxidant effect of PPARgamma is exclusively mediated by GPx3 and further imply that GPx3 may be a therapeutic target for insulin resistance and diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242985.RAP6X7qo53l3MJdcHHWYo7WcYq0nnk5th59nRek1qCqZs130_provenance.
- NP242986.RA2hwKyjNZOLgqo_oZfAycNO3YM6geC7weMiPFrk_3WnA130_assertion description "[The antioxidant effect of PPARgamma is exclusively mediated by GPx3 and further imply that GPx3 may be a therapeutic target for insulin resistance and diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP242986.RA2hwKyjNZOLgqo_oZfAycNO3YM6geC7weMiPFrk_3WnA130_provenance.